2.16
Precedente Chiudi:
$2.16
Aprire:
$2.16
Volume 24 ore:
42,224
Relative Volume:
0.09
Capitalizzazione di mercato:
$153.62M
Reddito:
-
Utile/perdita netta:
$-117.50M
Rapporto P/E:
-0.90
EPS:
-2.4
Flusso di cassa netto:
$-114.31M
1 W Prestazione:
+12.83%
1M Prestazione:
+30.51%
6M Prestazione:
-7.81%
1 anno Prestazione:
-69.23%
Nkarta Inc Stock (NKTX) Company Profile
Nome
Nkarta Inc
Settore
Industria
Telefono
(925) 407-1049
Indirizzo
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Confronta NKTX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NKTX
Nkarta Inc
|
2.165 | 153.27M | 0 | -117.50M | -114.31M | -2.40 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
467.26 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
565.32 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
329.83 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.99 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-15 | Downgrade | William Blair | Outperform → Mkt Perform |
2024-10-09 | Iniziato | Rodman & Renshaw | Buy |
2024-08-14 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2024-03-22 | Downgrade | Raymond James | Strong Buy → Outperform |
2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
2022-10-10 | Iniziato | Canaccord Genuity | Buy |
2022-07-28 | Iniziato | Needham | Buy |
2022-07-18 | Iniziato | SVB Leerink | Outperform |
2022-03-11 | Iniziato | Raymond James | Outperform |
2022-03-08 | Iniziato | H.C. Wainwright | Buy |
2022-01-06 | Iniziato | William Blair | Outperform |
2021-11-18 | Iniziato | SMBC Nikko | Outperform |
2021-07-16 | Iniziato | Oppenheimer | Outperform |
2020-08-04 | Iniziato | Cowen | Outperform |
2020-08-04 | Iniziato | Evercore ISI | Outperform |
2020-08-04 | Iniziato | Mizuho | Buy |
2020-08-04 | Iniziato | Stifel | Buy |
Mostra tutto
Nkarta Inc Borsa (NKTX) Ultime notizie
Why Nkarta Inc. stock attracts strong analyst attentionMachine Learning Stock Movement Detector - Newser
Custom strategy builders for tracking Nkarta Inc.Free News Based Entry Opportunity Alerts - Newser
What markets is ATCO.PRD expanding into Is Nkarta Inc. stock a good long term investment optionUnlock your portfolio’s hidden potential - jammulinksnews.com
What are analysts’ price targets for Nkarta Inc. in the next 12 monthsDiscover undervalued stocks before they soar - jammulinksnews.com
What catalysts could drive Nkarta Inc. stock higher in 2025Explosive capital appreciation - jammulinksnews.com
When is Nkarta Inc. stock expected to show significant growthGet daily expert analysis for smarter investing - jammulinksnews.com
Published on: 2025-07-28 05:39:49 - jammulinksnews.com
What is the risk reward ratio of investing in Nkarta Inc. stockGet daily updates on top-performing stocks - jammulinksnews.com
What is the dividend policy of Nkarta Inc. stockFree Technical Analysis Support - jammulinksnews.com
How Interest Rate Changes Impact Nkarta Inc. Stock PerformanceCarefully Curated High Return Stocks - Newser
Top Risks to Consider Before Buying Nkarta Inc. Stock5x Profit Potential - Newser
Is Nkarta Inc. Stock Overbought or Oversold RSI Indicator AnalysisTargeted 200 Percent Gain - Newser
What makes Nkarta Inc. stock price move sharplyElite Stock Shortlist - metal.it
Nkarta Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia
What drives Nkarta Inc. stock priceFree Stock Market Knowledge Sharing - Autocar Professional
What analysts say about Nkarta Inc. stockFree Advanced Stock Screener Access - Autocar Professional
How high can Nkarta Inc. stock price go in 2025Outstanding investment returns - jammulinksnews.com
The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains - MedCity News
Nkarta to Participate in the H.C. Wainwright “HCW@Home” Series - GlobeNewswire
Is Nkarta Inc. a good long term investmentFree Technical Analysis Support - Autocar Professional
How Nkarta Inc. stock performs during market volatilityFree Consultation - Newser
Nkarta: Holding Its Support Steady Ahead Of First Data Readouts In 2025 - Seeking Alpha
Nkarta Inc Azioni (NKTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nkarta Inc Azioni (NKTX) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Shook David | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
8,638 |
19,004 |
190,955 |
Levin Alyssa | See Remarks |
Jan 15 '25 |
Sale |
2.20 |
5,838 |
12,844 |
102,662 |
Brandenberger Ralph | Chief Technical Officer |
Jan 15 '25 |
Sale |
2.20 |
7,447 |
16,383 |
124,796 |
HASTINGS PAUL J | Chief Executive Officer |
Jan 15 '25 |
Sale |
2.20 |
17,378 |
38,232 |
319,859 |
Hager Alicia J. | Chief Legal Officer |
Jan 15 '25 |
Sale |
2.20 |
9,584 |
21,085 |
146,735 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):